PAION

PAION, a biopharmaceutical company based in Aachen, Germany, aims to become a leader in developing and commercialising innovative drugs for the treatment of stroke and other thrombotic diseases for which there is a substantial unmet medical need. PAION intends to build an integrated portfolio of drugs by exploiting its core expertise in identifying compounds with potential in the treatment of stroke and other thrombotic diseases, licensing or otherwise acquiring these compounds and advancing them through the clinical development and regulatory approval process.
Currently, PAION’s activities are focused on the development of the three drugs Desmoteplase, Enecadin, and Solulin. PAION’s most advanced substance, Desmoteplase, has received fast-track designation from the U.S. Food and Drug Administration for the indication acute ischemic stroke and the company started a Phase III study with the substance in 2005 together with Forest Laboratories.
In 2005, PAION employed on average 72 people. Since 11 February 2005, PAION is listed at the Frankfurt Stock Exchange (Prime Standard Official Market, Stock Symbol PA8, ISIN DE000A0B65S3).

Contact Details: Martinstrasse 10-12 Aachen 52062 Germany Tel: 49-(0)241-4453-0 Fax: 49-(0)241-4453-100 Email: info@paion.de WWW: www.paion.de/

Recent Publications by PAION:
Vampire bat plasminogen activator DSPA-alpha-1 (desmoteplase): a thrombolytic drug optimized by natural selection. Plasminogen activators are enzymes found in all vertebrate species...	3rd September, 2003	Paion GmbH, Research Center Berlin, Tegeler Weg 33, D-10589 Berlin,	Haemostasis. 2001 May-Dec;31(3-6):118-22.

Press Releases on PAION:
Reportlinker Adds Anticoagulants - A Global Market Review	18th November, 2009	Reportlinker	NEW YORK, Nov. 18 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue. Anticoagulants - A Global Market Review http://www.reportlinker.com

BioNews Results for PAION:
PharmaCell B.V. appoints new CEO	Bionity.com:  Nov 3 2009 2:41PM Matching: paion
PAION Completes Enrollment For Phase IIa Study With CNS 7056	Pharmaceutical Business Review:  Sep 8 2009 3:34PM Matching: paion

PAION Patents:
US Patent No.	Title
6804731	System, method and article of manufacture for storing an incoming datagram in switch matrix in a switch fabric chipset system
6731631	System, method and article of manufacture for updating a switching table in a switch fabric chipset system
6724759	System, method and article of manufacture for transferring a packet from a port controller to a switch fabric in a switch fabric chipset system

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 269 times since April 2007, the link to the organisation's website has been followed 57 times

Search for more companies in Aachen

Search for more companies in

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for PAION